Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > Howhee..where are you on this?

<< Previous

Bullboard Posts

Next >>

Comment by lscfaon Jul 29, 2022 5:12pm

103 Views

Post# 34861258

RE:Howhee..where are you on this?

we have to wait to the end of Sept fins to see if the upfront payment was $100,000 or $1,000,000. Nothing in the interim will move this damn stock.

Tickel1st wrote: The Board has begun a strategic review of every facet of the company including management, organizational structure, project pipeline, financial position and the exchanges on which the Sirona shares are listed.

What is being reviewed and what is the progress? Give us an update on management....then organizational structure, then project pipeline, then financial position and finally exchanges.

I'm thinking cats...I've never been a cat person but I'm liking them more and more if they can keep this pile of rotting stock certificates from going to 5 cents.

Go Cat Team Go.